These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 9593551

  • 1. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA.
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
    Sollinger HW.
    Transplantation; 1995 Aug 15; 60(3):225-32. PubMed ID: 7645033
    [Abstract] [Full Text] [Related]

  • 3. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
    Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE.
    J Heart Lung Transplant; 2004 Mar 15; 23(3):334-51. PubMed ID: 15019644
    [Abstract] [Full Text] [Related]

  • 4. Individualization of mycophenolate mofetil dose in renal transplant recipients.
    van Hest RM, Hesselink DA, Vulto AG, Mathot RA, van Gelder T.
    Expert Opin Pharmacother; 2006 Mar 15; 7(4):361-76. PubMed ID: 16503809
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
    Fulton B, Markham A.
    Drugs; 1996 Feb 15; 51(2):278-98. PubMed ID: 8808168
    [Abstract] [Full Text] [Related]

  • 6. Mycophenolate mofetil.
    Sievers TM, Rossi SJ, Ghobrial RM, Arriola E, Nishimura P, Kawano M, Holt CD.
    Pharmacotherapy; 1997 Feb 15; 17(6):1178-97. PubMed ID: 9399601
    [Abstract] [Full Text] [Related]

  • 7. Enteric-coated mycophenolate-sodium in heart transplantation: efficacy, safety, and pharmacokinetic compared with mycophenolate mofetil.
    Lehmkuhl H, Hummel M, Kobashigawa J, Ladenburger S, Rothenburger M, Sack F, Dengler T, Hetzer R.
    Transplant Proc; 2008 May 15; 40(4):953-5. PubMed ID: 18555088
    [Abstract] [Full Text] [Related]

  • 8. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
    Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, Costanzo M, Eisen H, Dureau G, Ratkovec R, Hummel M, Ipe D, Johnson J, Keogh A, Mamelok R, Mancini D, Smart F, Valantine H.
    Transplantation; 1998 Aug 27; 66(4):507-15. PubMed ID: 9734496
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil (MMF) in heart transplantation: rejection prevention and treatment.
    Renlund DG, Gopinathan SK, Kfoury AG, Taylor DO.
    Clin Transplant; 1996 Feb 27; 10(1 Pt 2):136-9. PubMed ID: 8680051
    [Abstract] [Full Text] [Related]

  • 10. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA, Meiser BM.
    Transplantation; 2005 Oct 15; 80(2 Suppl):S235-43. PubMed ID: 16251856
    [Abstract] [Full Text] [Related]

  • 11. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
    Transplantation; 1996 Apr 15; 61(7):1029-37. PubMed ID: 8623181
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
    Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Barker C.
    Transplantation; 1997 Jan 15; 63(1):39-47. PubMed ID: 9000658
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolic acid levels in pediatric heart transplant recipients receiving mycophenolate mofetil.
    Dipchand AI, Pietra B, McCrindle BW, Rosebrook-Bicknell HL, Boucek MM.
    J Heart Lung Transplant; 2001 Oct 15; 20(10):1035-43. PubMed ID: 11595558
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO, Ensley RD, Olsen SL, Dunn D, Renlund DG.
    J Heart Lung Transplant; 1994 Oct 15; 13(4):571-82. PubMed ID: 7947873
    [Abstract] [Full Text] [Related]

  • 15. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
    Behrend M.
    Clin Nephrol; 1996 May 15; 45(5):336-41. PubMed ID: 8738667
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar 15; 61(5):722-9. PubMed ID: 8607174
    [Abstract] [Full Text] [Related]

  • 17. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group.
    Lancet; 1995 May 27; 345(8961):1321-5. PubMed ID: 7752752
    [Abstract] [Full Text] [Related]

  • 18. [Use of mycophenolate mofetil in kidney transplantation].
    Hrvacevic R, Ignjatovic Lj, Vavic N.
    Vojnosanit Pregl; 2001 May 27; 58(4):415-9. PubMed ID: 11712223
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep 29; 37(958):84-6. PubMed ID: 7674993
    [No Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience.
    Dipchand AI, Benson L, McCrindle BW, Coles J, West L.
    Pediatr Transplant; 2001 Apr 29; 5(2):112-8. PubMed ID: 11328549
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.